Hong Kong Albert Yu, Chairman of the Hong Kong Biotechnology Organization, shares his insights on Hong Kong’s potential to become an innovation hub for the region while positioning Hong Kong as the ‘Chinese City outside of China.’ In addition, he discusses the main trends that will drive development of HK’s biotechnology sector…
Taiwan Chin Chun Lin, chairman of Taiwan Leader Biotech Corp., discusses the importance of herbal medicine for preventive healthcare, and shares valuable insights into Taiwan Leader Biotech Corp., a leading company in medicinal fungus, that established brand recognition through balancing social, economic and environmental perspectives while promoting the importance of the…
Taiwan Joshua Chang, CEO of RDD Lab, describes the scope of the company’s operations, the expansion of the firm’s capacities, and emerging trends in the CRO industry. Please begin by introducing yourself and the main operations and services of your CRO. “The local CRO industry has many advantages; the results of…
Taiwan Frank Douglas, CEO of the TheVax, discusses what he finds so inspiring about innovation in resource-constrained environments, and this Taiwanese biotech’s revolutionary SIT specific immunotherapy platform. The company was founded in 2012 with the mission to focus on the use of immunotherapy to address virus-induced tumors and infections in patients.…
Taiwan Eric Tsao, founder of Synermore Biologics, talks about how a company employing 90 people can successfully operate internationally and efficiently progress with its biosimilar and innovative product development pipeline. He also discusses what business strategy and potential partnerships will determine the successful growth of the company in the future. You…
Taiwan Ming-Kuei Jang, founder and CEO of Aprinoia, a very promising Taiwan-based company focused on the development of groundbreaking imaging tracers and therapeutics targeting tau-related neurodegenerative diseases, provides insights into the company’s rapid development over the past two years, its R&D strategy, and its eagerness to partner with both academia and…
Japan Eric Delarge, general manager and representative director of Servier Japan, recently became the first member of the international pharma industry to join bioIPSeeds, an innovative tool aiming to foster early stage collaboration between academia and the global industry, which also stands as the first application of the blockchain technology in…
Taiwan Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), provides insights into the recent development of the country’s innovative biopharmaceutical industry, while she also highlights TRPMA’s eye-catching initiative to promote international collaboration between Taiwan’s academia and the global industry, thanks to the recent set up of the association’s…
Taiwan Carol Cheng, COO of the Taiwan Research-based Biopharmaceutical Manufacturers Association (TRPMA), the association gathering 28 Taiwan-based, R&D-driven biopharmaceutical companies, highlights the association’s eye-catching initiative to boost international collaboration between academia and the global industry, thanks to the recent set up of the BioIPSeeds® platform, which proudly stands as the first…
Taiwan James Chen, founder and Chairman of the board of Vetco, the first Taiwan-based veterinary company to have successfully developed an innovative veterinary oncology product, documents the main specificities of Vetco’s flagship product, Antican®, as well as his strategy to bring this ground-breaking treatment onto the most advanced animal health markets…
Taiwan Johnsee Lee, founder, CEO, and president of Personal Genomics and its sister company Quark Biosciences, provides insights into the company’s proprietary Optoelectronic Sequencing (OES) technology, which can perform whole genome sequencing thousand times faster than existing technologies and increase read length twentyfold in comparison to sequencing products currently on the…
Taiwan Ben Chien, Chairman, President and CEO, of Foresee Pharmaceuticals, one of Taiwan’s most vibrant success stories, discusses how Foresee has achieved successful phase III results for its prostate cancer treatment, FP-001, IPOed and entered into a partnership agreement with Ferring in the last year alone. In addition, he discloses how…
See our Cookie Privacy Policy Here
